Author

J. Reimand

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Research Focus:gene regulatory network inference· 4 Research Focus:differential expression· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:chromatin & epigenetic regulation· 2 Approach:machine learning (classical)· 2 Research Focus:variant calling· 2

Frequent Co-Authors

A. T. Bahcheli· 2 shared D. Schramek· 2 shared I. Dzneladze· 2 shared K. Isaev· 2 shared M. Lupien· 2 shared P. B. Dirks· 2 shared P. Mazrooei· 2 shared A. Fortuna· 1 shared

Activity by Year

2017-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. T. Bahcheli

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Pan-cancer analysis of the ion permeome reveals functional regulators of glioblastoma aggression

A. T. Bahcheli, H.-K. Min, M. Bayati, W. Dong, A. Fortuna, H. Zhao, I. Dzneladze, J. Chan, X. Chen, K. Guevara-Hoyer, P. B. Dirks, X. Huang, J. Reimand

The paper identifies survival-associated ion permeome genes across 29 cancer types and shows their role in glioblastoma aggression through functional experiments.

bioRxiv · Apr 7, 2023Cancer Biology

Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes

N. Adler, A. T. Bahcheli, K. Cheng, K. N. Al-Zahrani, M. Slobodyanyuk, D. Pellegrina, D. Schramek, J. Reimand

The paper analyzes the impact of mutational signatures from tobacco smoking and APOBEC activity on protein-truncating mutations in 12,341 cancer genomes across 18 types, showing their enrichment in key cancer pathways and tumor suppressors.

bioRxiv · Mar 19, 2023Cancer Biology

Non-coding mutations reveal cancer driver cistromes in luminal breast cancer

S. El Ghamrasni, R. Quevedo, J. R. Hawley, P. Mazrooei, Y. Hanna, I. Cirlan, H. Zhu, J. P. Bruce, L. E. Oldfield, S. Y. C. Yang, P. Guilhamon, J. Reimand, D. Cescon, S. J. Done, M. Lupien, T. Pugh

The paper identifies cancer driver cistromes in luminal breast cancer by analyzing non-coding mutations in cis-regulatory elements from ATAC-seq data and integrating them with somatic mutations.

bioRxiv · May 29, 2021Cancer Biology

Comprehensive analysis of lncRNAs reveals candidate prognostic biomarkers in multiple cancer types

K. Isaev, L. Jiang, C. A. Lee, R. Tsai, F. Coutinho, P. B. Dirks, D. Schramek, J. Reimand

The paper identifies 179 prognostic lncRNAs across 29 cancer types using machine learning, showing their association with patient risk and tumor subtypes.

bioRxiv · Dec 2, 2019Cancer Biology

Candidate cancer driver mutations in super-enhancers and long-range chromatin interaction networks

L. Wadi, L. Uuskula-Reimand, K. Isaev, S. Shuai, V. Huang, M. Liang, D. Thompson, Y. Li, L. Ruan, M. Paczkowska, M. Krassowski, I. Dzneladze, K. Kron, A. Murison, P. Mazrooei, , J. Reimand

The paper identifies 41 frequently mutated regulatory elements in cancer genomes, enriched in non-coding mutations and linked to gene expression control through chromatin interactions.

bioRxiv · Dec 19, 2017Cancer Biology